We have developed an approach based on the synthetic sensitivity phenomenon of p53-negative cancer cells in the presence of overexpressed Wip1 phosphatase.6 Importantly, this approach allows specific targeting of only cancer cells, but not normal tissues. This evidence concerns the gene TP53 and cancer.